Also trades as: 0QF.F (FSX) · $vol 0M
MRNA NASDAQ
Moderna, Inc.
1W: -5.5%
1M: -15.0%
3M: -5.2%
YTD: +12.7%
1Y: +76.3%
3Y: -69.6%
5Y: -66.5%
$46.88
-0.38 (-0.80%)
Weekly Expected Move ±9.0%
$40
$45
$49
$53
$58
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.60
Bullish
2 bullish
1 neutral
0 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (100)
Bristol-Myers taps Anthropic's Claude for 30,000 workers
Top Research Reports for Visa, IBM & CrowdStrike
Notable healthcare headlines for the week: UnitedHealth, Bristol Myers Squibb, and Hims & Hers in focus
Wall Street trades mostly higher despite a hotter than forecasted PPI inflation print
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
Moderna's Revenues See Strong International Momentum in Q1 Earnings
Stock Market Today, May 11: Chipmakers Drive Midday Gains Despite Oil Concerns
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone?
Prediction-market traders put hantavirus pandemic risk at just 9%
Merck Stock Down 7% in a Month: Should Investors Hold or Exit?
Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb
Moderna Shares Surge On Hantavirus Concerns: What Investors Need To Know
Why Digi Power X Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Stock Market Today: S&P 500, Dow Futures Fall As Trump Rejects 'Totally Unacceptable' Iran Peace Proposal—Micron Technologies, Moderna In Focus
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Trump says unaware of a plan to fire FDA commissioner
What's Going On With Novavax Stock On Friday?
Trump to fire FDA commissioner Marty Makary: WSJ
Moderna jumps on word it is working on a hantavirus vaccine
Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know
Moderna Stock Gives Back Early Gains: What's Happening?
FDA halts publication of studies on COVID, shingles vaccines
FDA head Makary defends drug application rejections amid criticism
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
Notable healthcare headlines for the week: Merck, Eli Lilly, and GE HealthCare in focus
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
Moderna expects up to 10% 2026 revenue growth and $4.5B-$5B year-end cash, while targeting ~$4.2B cash costs
Moderna (MRNA) Q1 2026 Earnings Transcript
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales
FDA said to have named Katherine Szarama as acting CBER chief
Moderna's Legal Hit Steals Spotlight From Strong Sales
Moderna Reports Q1 2026 Results: Full Earnings Call Transcript
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates
Earnings Scheduled For May 1, 2026
Moderna jumps after strong Q1 beat driven by international sales
Moderna GAAP EPS of -$3.40 beats by $0.48, revenue of $389M beats by $153.53M
Here are the major earnings before the open Friday
Moderna Q1 preview: revenue rebound in focus as losses persist
Near the top of biotech rankings, AbbVie's Q1 beat makes a case for more upside
Moderna Gears Up to Report Q1 Earnings: Here's What to Expect
TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth
Earnings week ahead: MSFT, AAPL, GOOG, AMZN, META, XOM, CVX, KO, V, SBUX, F, GM, and more
Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
3 Healthcare Stocks With the Most Durable Competitive Moats
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
COVID vaccine report on cutting hospital visits blocked from publication in CDC journal
European Commission Approves MRNA's COVID-19-Influenza Combo Shot
Moderna starts late-stage trial for bird flu vaccine
Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth
Europe Clears First Flu/COVID Combo Shot From Moderna
Moderna granted EU nod for combined COVID-19 and flu vaccine
Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk
Merck Rises 11% YTD: Should Investors Buy, Sell or Hold the Stock?
What's Pushing Moderna Stock Higher Today?
Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last?
OpenAI launches GPT-Rosalind, an AI model for life sciences research
Trump nominates Erica Schwartz to lead CDC, ending months-long search
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
Baillie Gifford & Co. Sells 1,266,152 Shares of Moderna, Inc. $MRNA
A $2 Trillion IPO and the Space Economy
HHS Secretary RFK Jr. overhauls CDC vaccine advisory committee rules
Study Showing 50% Drop In COVID ER Visits Thanks To The Vaccine Put On Hold By CDC: Report
Moderna, Inc. $MRNA Shares Bought by Douglas Lane & Associates LLC
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Report on COVID vaccine benefits being delayed at CDC: WaPo
Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy?
Looks Like M&A Week in 3 Different Sectors
RFK Jr. changes rules to select CDC vaccine advisors after legal setback
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.
Florida Trust Wealth Management Co Invests $337,000 in Moderna, Inc. $MRNA
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Moderna (MRNA) Stock Dips While Market Gains: Key Facts
Amazon To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday
Stocks hedge funds love to short
Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat
Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags
S&P 500 logs weakest Q1 performance since 2022 - here’s what drove the moves
Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?
Oil Tumbles, Nasdaq 100 Jumps 3% As Iran Says It's Ready To Halt Hostilities: 10 Stocks Moving
Is Trump to blame for delayed drug launches in Europe
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know
Former CDC advisor says White House pulling back on vaccine policy
Why Is Alkermes (ALKS) Down 2.6% Since Last Earnings Report?
ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?
Merck Stock Soars 50% in 6 Months: Buy, Hold, or Take Profits?
2 Healthcare Stocks That Could Soar Over the Next 5 Years
Why Is Cytokinetics (CYTK) Down 0.8% Since Last Earnings Report?
White House misses deadline for CDC director nominee
Moderna Stock is Soaring. Is It Too Late to Buy?
Myriad (MYGN) Up 4.1% Since Last Earnings Report: Can It Continue?
Moderna stands as the best performing large-cap healthcare stock YTD
Top performing large-cap stocks YTD as volatility hits markets
Hudson Bay Capital Management LP Lowers Stake in Moderna, Inc. $MRNA
Trump administration reportedly shortlisting CDC nominees
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?
Pfizer vs Moderna: Which Pharma Stock Has More Upside?